PROlectin M, a Nucleocapsid TErminal GaleCTin Antagonist for COVID-19

Clinical trial NCT05096052 · UNKNOWN

Trial details

NCT number: NCT05096052
Sponsor: Bioxytran Inc.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 COVID-19 Pandemic COVID-19 Respiratory Infection SARS-CoV2 Infection Cytokine Release Syndrome

Start date: 2022-04-01
Primary completion: 2022-07-31
Enrollment: 408

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.